Literature DB >> 2369588

The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins.

P J Barter1, L B Chang, H H Newnham, K A Rye, O V Rajaram.   

Abstract

Purified human cholesteryl ester transfer protein (CETP) has been found, under certain conditions, to promote changes to the particle size distribution of high-density lipoproteins (HDL) which are comparable to those attributed to a putative HDL conversion factor. When preparations of either the conversion factor or CETP are incubated with HDL3 in the presence of very-low-density lipoproteins (VLDL) or low-density lipoproteins (LDL), the HDL3 are converted to very small particles. The possibility that the conversion factor may be identical to CETP was supported by two observations: (1) CETP was found to be the main protein constituent of preparations of the conversion factor and (2) an antibody to CETP not only abolished the cholesteryl ester transfer activity of the conversion factor preparations but also inhibited changes to HDL particle size. In additional studies, the changes to HDL particle size promoted by purified CETP were inhibited by the presence of fatty-acid-free bovine serum albumin; by contrast, albumin had no effect on the cholesteryl ester transfer activity of the CETP. The possibility that albumin may inhibit changes to HDL particle size by removing unesterified fatty acids from either the lipoproteins or CETP was tested by adding exogenous unesterified fatty acids to the incubations. In incubations of HDL with either VLDL or LDL, sodium oleate had no effect on HDL particle size. However, when CETP was also present in the incubation mixtures the capacity of CETP to reduce the particle size of HDL was greatly enhanced by the addition of sodium oleate. It is concluded that the changes in HDL particle size which were previously attributed to an HDL conversion factor can be explained in terms of the interacting effects of CETP and unesterified fatty acids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369588     DOI: 10.1016/0005-2760(90)90206-d

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy.

Authors:  Rajagopal V Sekhar; Farook Jahoor; Henry J Pownall; Christie M Ballantyne; Ashok Balasubramanyam
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

2.  Effects of charged lipids on the interaction of cholesteryl ester transfer protein with lipid microemulsions.

Authors:  O V Rajaram; W H Sawyer
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  Changes in high density lipoprotein subfraction lipids during neutral lipid transfer in healthy subjects and in patients with insulin-dependent diabetes mellitus.

Authors:  M C Ritter; J D Bagdade
Journal:  Lipids       Date:  1996-01       Impact factor: 1.880

4.  Effect of unesterified cholesterol on the activity of cholesteryl ester transfer protein.

Authors:  O V Rajaram; R Y Chan; W H Sawyer
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

5.  Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux.

Authors:  Alexei V Navdaev; Lorenzo Sborgi; Samuel D Wright; Svetlana A Didichenko
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-05       Impact factor: 8.311

6.  APOE, CETP and LPL genes show strong association with lipid levels in Greek children.

Authors:  M C Smart; G Dedoussis; E Louizou; M Yannakoulia; F Drenos; C Papoutsakis; N Maniatis; S E Humphries; P J Talmud
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-28       Impact factor: 4.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.